Pyrrolidinone derivatives
US6936633B2 · kind B2 · utility
6Cited by
0References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 31, 2003 |
| Grant date | Aug 30, 2005 |
| Priority date | — |
| Expiry date | Feb 9, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides pharmaceutical compositions and novel compounds useful in the treatment of conditions mediated by CCR2, MCP-1 or the interaction thereof. The compounds of the present invention are pyrrolidinones and pyrrolidine-thiones.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.